JPRN-jRCT2080220215未知2 期
A study of peginterferon alfa-2a in combination with ribavirin in chronic hepatitis C(CHC) patients with compensated liver cirrhosis(LC).
适应症
试验速览
- 阶段
- 2 期
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 <= 75age old（—）
- 性别
- All
入选标准
- •Male and Female patients aged 20 to 75 years-old, diagnosed CHC with compensated LC, elevated ALT and detectable HCV RNA.
排除标准
- 未提供
研究者
相似试验
未知
3 期
A study of peginterferon alfa-2a in combination with ribavirin in patients with chronic Hepatitis C.Chronic hepatitis CJPRN-jRCT2080220023Chugai Pharmaceutical Co., Ltd.
已完成
3 期
The effect of Combination Peg interferon –alpha to Tenofovir versus each one of the treatment modalities alone on Patients with HBeAg-negative: A randomized clinical trialIRCT20181113041635N1vice presidency for siences and technology , Iran national silences foundation60
已完成
3 期
Effect of Pegylated Interferon alfa-2a plus Adefovir in the treatment of chronic hepatitis B with genotype DChronic hepatitis B.Chronic viral hepatitis B without delta-agentIRCT138711201155N4Guilan University of Medical Sciences74
已完成
不适用
The effectiveness of peginterferon -alpha2a and the entecavir combination therapy for the chronic hepatitis B patientJPRN-UMIN000016275Kinki University School of Medicine50
已完成
不适用
A dose comparing study of peginterferon alfa-2b plus ribavirin in chronic hepatitis type C except genotype 1 and high pretreatment viremia.: A randomized open-label pilot study.JPRN-C000000313Hiroshima liver study group120